Molecular mechanisms of IL-18BP regulation in DLD-1 cells: Pivotal direct action of the STAT1/GAS axis on the promoter level

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 8 B, 2009, Pages 1987-1994

  Bachmann, Malte ^a   Paulukat, Jens ^a,b   Pfeilschifter, Josef ^a   Mühl, Heiko ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b InfectoPharm   (Germany)

Author keywords

IL 18 binding protein; Interferon ; STAT1

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN-18 BINDING PROTEIN; PRIMER DNA; SIGNAL PEPTIDE; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN;

ARTICLE; GEL MOBILITY SHIFT ASSAY; GENETICS; HUMAN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMOTER REGION; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON-GAMMA; PROMOTER REGIONS, GENETIC; STAT1 TRANSCRIPTION FACTOR;

EID: 69849090731     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00604.x     Document Type: Article

References (34)

1. Boraschi D, Dinarello CA. IL-18 in autoimmunity: review. Eur Cytokine Netw. 2006 17 : 224 252.
2. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev. 2008 223 : 20 38.
3. Mühl H, Pfeilschifter J. Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention. Eur J Pharmacol. 2004 500 : 63 71.
4. Puren AJ, Fantuzzi G, Gu Y, et al. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest. 1998 101 : 711 721.
5. Netea MG, Kullberg BJ, Verschueren I, et al. Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. Eur J Immunol. 2000 30 : 3057 3060.
6. Siegmund B, Fantuzzi G, Rieder F, et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol. 2001 281 : R1264 R73.
7. Canetti CA, Leung BP, Culshaw S, et al. IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-alpha and leukotriene B4. J Immunol. 2003 171 : 1009 1015.
8. Novick D, Kim SH, Fantuzzi G, et al. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity. 1999 10 : 127 136.
9. Aizawa Y, Akita K, Taniai M, et al. Cloning and expression of interleukin-18 binding protein. FEBS Lett. 1999 445 : 338 342.
10. Mühl H, Pfeilschifter J. Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int Immunopharmacol. 2003 3 : 1247 1255.
11. Kim SH, Eisenstein M, Reznikov L, et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Sci USA. 2000 97 : 1190 1195.
12. Novick D, Schwartsburd B, Pinkus R, et al. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine. 2001 14 : 334 342.
13. Corbaz A, ten Hove T, Herren S, et al. IL-18 binding protein expression by endothelial cells and macrophages is upregulated during active Crohn's disease. J Immunol. 2002 168 : 3608 3616.
14. Ohta Y, Hamada Y, Katsuoka K. Expression of IL-18 in psoriasis. Arch Dermatol Res. 2001 293 : 334 342.
15. Novick D, Elbitt D, Dinarello CA, et al. Interleukin-18 binding protein in the sera of patients with Wegener's granulomatosis. J Clin Immunol. 2009 29 : 38 45.
16. Smith VP, Bryant NA, Alcami A. Ectromelia, vaccinia and cowpox viruses encode secreted Interleukin-18 binding proteins. J Gen Virol. 2000 81 : 1223 1230.
17. Mühl H, Kämpfer H, Bosmann M, et al. Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. Biochem Biophys Res Commun. 2000 267 : 960 963.
18. Paulukat J, Bosmann M, Nold M, et al. Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol. 2001 167 : 7038 7043.
19. Möller B, Paulukat J, Nold M, et al. Interferon-gamma induces expression of interleukin-18 binding protein in fibroblast-like synoviocytes. Rheumatology. 2003 42 : 442 445.
20. Hurgin V, Novick D, Rubinstein M. The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta. Proc Natl Acad Sci USA. 2002 99 : 16957 16962.
21. Hurgin V, Novick D, Werman A, et al. Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1alpha. Proc Natl Acad Sci USA. 2007 104 : 5044 5049.
22. Ziesché E, Bachmann M, Kleinert H, et al. The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells. J Biol Chem. 2007 282 : 16006 16015.
23. Taniguchi T, Ogasawara K, Takaoka A, et al. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol. 2001 19 : 623 655.
24. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signaling. Nat Rev Immunol. 2005 5 : 375 386.
25. Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004 75 : 163 189.
26. Jin Y, Heck DE, DeGeorge G, et al. 5-Fluorouracil suppresses nitric oxide biosynthesis in colon carcinoma cells. Cancer Res. 1996 56 : 1978 1982.
27. Pautz A, Linker K, Hubrich T, et al. The polypyrimidine tract-binding protein (PTB) is involved in the post-transcriptional regulation of human inducible nitric oxide synthase expression. J Biol Chem. 2006 281 : 32294 32302.
28. Leach ST, Messina I, Lemberg DA, et al. Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease. Inflamm Bowel Dis. 2008 14 : 68 74.
29. Pagès F, Berger A, Henglein B, et al. Modulation of interleukin-18 expression in human colon carcinoma: consequences for tumor immune surveillance. Int J Cancer. 1999 84 : 326 330.
30. Kalvakolanu DV, Roy SK. CCAAT/enhancer binding proteins and interferon signaling pathways. J Interferon Cytokine Res. 2005 25 : 757 769.
31. Robinson CM, Hale PT, Carlin JM. NF-kappa B activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-gamma and tumor necrosis factor-alpha. Cytokine. 2006 35 : 53 61.
32. Tamassia N, Calzetti F, Ear T, et al. Molecular mechanisms underlying the synergistic induction of CXCL10 by LPS and IFN-gamma in human neutrophils. Eur J Immunol. 2007 37 : 2627 2634.
33. Kleinert H, Wallerath T, Fritz G, et al. Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways. Br J Pharmacol. 1998 125 : 193 201.
34. Hellmuth M, Wetzler C, Nold M, et al. Expression of interleukin-8, heme oxygenase-1, and vascular endothelial growth factor in DLD-1 colon carcinoma cells exposed to pyrrolidine dithiocarbamate. Carcinogenesis. 2002 23 : 1273 1279.